aldosterone has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 3 studies
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Longer duration or higher dosage of spironolactone seems to be more effective in improving cardiovascular system status in PD patients." | 5.46 | Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients. ( Donderski, R; Grajewska, M; Manitius, J; Miśkowiec, I; Odrowąż-Sypniewska, G; Siódmiak, J; Stefańska, A; Stróżecki, P; Sulikowska, B, 2017) |
| " Longer duration or higher dosage of spironolactone seems to be more effective in improving cardiovascular system status in PD patients." | 1.46 | Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients. ( Donderski, R; Grajewska, M; Manitius, J; Miśkowiec, I; Odrowąż-Sypniewska, G; Siódmiak, J; Stefańska, A; Stróżecki, P; Sulikowska, B, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donderski, R | 1 |
| Stróżecki, P | 1 |
| Sulikowska, B | 1 |
| Grajewska, M | 1 |
| Miśkowiec, I | 1 |
| Stefańska, A | 1 |
| Siódmiak, J | 1 |
| Odrowąż-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Fujii, H | 1 |
| Watanabe, K | 1 |
| Kono, K | 1 |
| Goto, S | 1 |
| Watanabe, S | 1 |
| Nishi, S | 1 |
| Sasaki, H | 1 |
| Higa, K | 1 |
| Asano, T | 1 |
| Hirahashi, T | 1 |
| Okumura, M | 1 |
| Kawasaki, T | 1 |
| Eto, T | 1 |
| Onoyama, K | 1 |
| Takebayashi, S | 1 |
3 other studies available for aldosterone and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Blood Pressure; Cardiovascular Diseases; Ch | 2017 |
Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats.
Topics: Aldosterone; Animals; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Mode | 2019 |
[A case of Bartter's syndrome with special referrence to the pathogenesis (author's transl)].
Topics: Adult; Aldosterone; Bartter Syndrome; Chronic Kidney Disease-Mineral and Bone Disorder; Electrolytes | 1977 |